Pfizer Inc.

-1.28 (-2.37%)
5:00:57 PM EDT: $52.60 -0.17 (-0.32%)

Pfizer Says To Provide UK Additional 2.5 Mln Treatment Courses Of Investigational Oral Antiviral Candidate To Combat COVID-19

Published: 12/22/2021 08:02 GMT
Pfizer Inc. (PFE) - Pfizer to Provide the United Kingdom an Additional 2.5 Million Treatment Courses of Investigational Oral Antiviral Candidate to Help Combat Covid-19.
A Total of 2.75 Million Doses Expected to Be Delivered to Uk Through 2022, Subject to Regulatory Approval Or Authorization.
Co Seeking Conditional Marketing Authorization of Paxlovid With Mhra.
Initiated Manufacturing of Paxlovid Earlier This Year & Expects to Produce Up to 80 Million Courses of Treatment by 2022, With 30 Million Treatment Courses Available in First Half of Year.